Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2016 1
2017 1
2018 4
2019 13
2020 9
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Results by year
Filters applied: . Clear all
Page 1
Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: Real-life data from a large cohort during red-zone declaration.
Damiani G, Pacifico A, Bragazzi NL, Malagoli P. Damiani G, et al. Among authors: malagoli p. Dermatol Ther. 2020 Sep;33(5):e13475. doi: 10.1111/dth.13475. Epub 2020 May 19. Dermatol Ther. 2020. PMID: 32356577 Free PMC article.
Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study.
Torres T, Balato A, Conrad C, Conti A, Dapavo P, Ferreira P, Gaiani F, Leite L, Malagoli P, Mendes-Bastos P, Megna M, Messina F, Nidegger A, Odorici G, Piaserico S, Prignano F, Ribero S, Ricceri F, Tonini A, Valério J, Chiricozzi A. Torres T, et al. Among authors: malagoli p. J Am Acad Dermatol. 2019 Jul;81(1):273-275. doi: 10.1016/j.jaad.2019.02.031. Epub 2019 Feb 18. J Am Acad Dermatol. 2019. PMID: 30790602 No abstract available.
The Impact of Intermittent Fasting (Ramadan Fasting) on Psoriatic Arthritis Disease Activity, Enthesitis, and Dactylitis: A Multicentre Study.
Adawi M, Damiani G, Bragazzi NL, Bridgewood C, Pacifico A, Conic RRZ, Morrone A, Malagoli P, Pigatto PDM, Amital H, McGonagle D, Watad A. Adawi M, et al. Among authors: malagoli p. Nutrients. 2019 Mar 12;11(3):601. doi: 10.3390/nu11030601. Nutrients. 2019. PMID: 30871045 Free PMC article.
Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study.
Chiricozzi A, Balato A, Conrad C, Conti A, Dapavo P, Ferreira P, Gaiani FM, Leite L, Malagoli P, Mendes-Bastos P, Megna M, Messina F, Nidegger A, Odorici G, Panduri S, Piaserico S, Piscitelli L, Prignano F, Ribero S, Valerio J, Torres T. Chiricozzi A, et al. Among authors: malagoli p. J Dermatolog Treat. 2020 Aug;31(5):476-483. doi: 10.1080/09546634.2019.1671577. Epub 2019 Oct 2. J Dermatolog Treat. 2020. PMID: 31557063 Clinical Trial.
COVID-19 knowledge prevents biologics discontinuation: Data from an Italian multicenter survey during RED-ZONE declaration.
Bragazzi NL, Riccò M, Pacifico A, Malagoli P, Kridin K, Pigatto P, Damiani G. Bragazzi NL, et al. Among authors: malagoli p. Dermatol Ther. 2020 Jul;33(4):e13508. doi: 10.1111/dth.13508. Epub 2020 May 28. Dermatol Ther. 2020. PMID: 32415727 Free PMC article.
Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study.
Chiricozzi A, Burlando M, Caldarola G, Conti A, Damiani G, De Simone C, Dini V, Malagoli P, Peccerillo F, Potenza C, Scala E, Skroza N, Balato A. Chiricozzi A, et al. Among authors: malagoli p. Am J Clin Dermatol. 2020 Jun;21(3):441-447. doi: 10.1007/s40257-019-00490-2. Am J Clin Dermatol. 2020. PMID: 31786732
Switching from Secukinumab to Ustekinumab in Psoriasis Patients: Results from a Multicenter Experience.
Chiricozzi A, Conti A, Burlando M, Odorici G, Gaiani F, Panduri S, Malagoli P. Chiricozzi A, et al. Among authors: malagoli p. Dermatology. 2019;235(3):213-218. doi: 10.1159/000497274. Epub 2019 Mar 29. Dermatology. 2019. PMID: 30928971
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis.
Scala E, Megna M, Amerio P, Argenziano G, Babino G, Bardazzi F, Bianchi L, Caldarola G, Campanati A, Cannavò SP, Chiricozzi A, Conti A, Damiani G, Dapavo P, De Simone C, Esposito M, Fabbrocini G, Fargnoli MC, Ferrara F, Fidanza R, Gualdi G, Guarneri C, Hansel K, Malagoli P, Malara G, Micali G, Mugheddu C, Musumeci ML, Odorici G, Offidani A, Pescitelli L, Prignano F, Raimondo A, Ribero S, Rongioletti F, Stingeni L, Trifirò C, Zanframundo S, Balato A. Scala E, et al. Among authors: malagoli p. PLoS One. 2020 Aug 12;15(8):e0237267. doi: 10.1371/journal.pone.0237267. eCollection 2020. PLoS One. 2020. PMID: 32785291 Free PMC article.
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis.
Gisondi P, Geat D, Conti A, Dapavo P, Piaserico S, De Simone C, Bianchi L, Costanzo A, Malagoli P, Malara G, Micali G, Naldi L, Offidani A, Patrizi A, Prignano F, Parodi A, Rongioletti F, Calzavara-Pinton P, Girolomoni G. Gisondi P, et al. Among authors: malagoli p. Expert Rev Clin Immunol. 2020 Jun;16(6):591-598. doi: 10.1080/1744666X.2020.1771182. Epub 2020 Jun 4. Expert Rev Clin Immunol. 2020. PMID: 32419534
Predicting Secukinumab Fast-Responder Profile in Psoriatic Patients: Advanced Application of Artificial-Neural-Networks (ANNs).
Damiani G, Conic RRZ, Pigatto PDM, Carrera CG, Franchi C, Cattaneo A, Malagoli P, Uppala R, Linder D, Bragazzi NL, Grossi E. Damiani G, et al. Among authors: malagoli p. J Drugs Dermatol. 2020 Dec 1;19(12):1241-1246. doi: 10.36849/JDD.2020.5006. J Drugs Dermatol. 2020. PMID: 33346505
27 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback